CoChat

Suicidal misophonia: a case report

Open access
Alekri, Jehad, Al Saif, Feras · 2019 · Psychiatry and Clinical Psychopharmacology

The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index; 4 of the 15 sources its claims cite were checked for support.

Abstract

Misophonia is still an unclassified disorder and means literally “strong dislike (hate) of sounds”. In this paper, we present a case report of an adolescent female who had misophonia that was complicated with two non-fatal suicide attempts. She presented with anxiety features and started to follow up for three years. Assessment of the level of misophonia for a year using Amsterdam Misophonia Scale (A-MISO-S) showed an extreme degree soon after the second suicide attempt. Initially, psychotherapy was noticed to be ineffective due to her poor motivation. Escitalopram was added to the management plan and improvement was reported in the depressive symptoms and obsessional thoughts of misophonia but were intolerable eventually because of the weight gain. Therefore, it was switched into Fluoxetine and Bupropion but six weeks later she attempted her second suicide by Bupropion overdose. At that point, the psychiatrist, the patient and her parents agreed to continue therapy with non-psychopharmacological treatment. Gradually she became more engaged in psychotherapy sessions after noticing its effectiveness. It was concluded that significant improvement of misophonia was reported when she was treated by Selective Serotonin Reuptake Inhibitors (SSRI) namely Escitalopram or Fluoxetine, motivated in psychotherapy sessions, adapted good coping strategies, decreased her dysfunctional challenging behaviour, rejoined social interaction and activity in her life, was more insightful and aware about her illness and developed self-acceptance. © 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Overview

CoChat Summary

TL;DR

This case report describes an 18-year-old female in Bahrain with misophonia, anxiety, depression, and two non-fatal suicide attempts. Her misophonia severity was extreme on the Amsterdam Misophonia Scale after the second attempt and improved by 47.8% over one year with psychotherapy and non-psychopharmacological management after medication trials were complicated by weight gain and overdose.

Key findings

  • A-MISO-S total was 23 (extreme) soon after the second suicide attempt, 16 at 3 months, and 12 at 12 months, corresponding to a total 47.8% reduction during one-year adherence to the management plan.
  • Escitalopram 20 mg/day and later fluoxetine 20–40 mg/day plus bupropion 150 mg/day were associated with improvement in depressive and obsessional misophonia symptoms, but escitalopram/mirtazapine was stopped after weight increased from 51 kg to 54 kg and then 59 kg; she developed atypical bulimia nervosa and later attempted suicide by taking around 30 bupropion tablets.
  • Psychotherapy was initially ineffective due to poor motivation; after the second suicide attempt, she engaged in 20 psychotherapy sessions over one year and used earplugs, headsets, music, self-distraction, and positive internal dialogue. Severity fell from extreme to severe (30.4% reduction) and then severe to moderate (additional 17.4% reduction).
  • SCID-I at initial presentation revealed no mental disorders; MMPI in 12/2018 reported no personality disorders; BMI was 19.5; family history included OCD in her father and several relatives, with no family member reported to have misophonia.

Methods

  • Single case report of an 18-year-old female student living with her parents in Bahrain, followed irregularly in the Anxiety Department for three years, with consent from the patient and her father.
  • Assessments included SCID-I at initial presentation in 12/2015, A-MISO-S soon after the second suicide attempt in 12/2017 and at 3 and 12 months post-suicide, and MMPI in 12/2018.
  • Management included psychoeducation, psychotherapy, escitalopram, mirtazapine, fluoxetine, bupropion, and eventually continuation with non-psychopharmacological treatment.

Limitations

  • The paper states there is still no study on the validity or reliability of the A-MISO-S, no study yet on the effectiveness of psychotropics in misophonia, and that it could not identify whether improvement on escitalopram or fluoxetine was a direct effect or indirect through treating comorbid depression and anxiety.
  • Evident from the text: this is a single case report with no control group, irregular follow-up, multiple concurrent treatments and psychosocial changes, so causality cannot be established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/24750573.2019.1597585

Cites

18 of 19 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Figure 1 Amsterdam Misophonia Scale (A-MISO-S).
Figure 1 Amsterdam Misophonia Scale (A-MISO-S).CC-BY · From the PDF

Verification

Claims the paper makes

4 Valid · 0 Not valid · 10 Not checked · 18 Own results and interpretations

6 more claims

Create a free account to see all 32 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 10
  • The quote only partly states this claim. 5
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Citations

Cites

Show all 19 references

Research works printed but not linked: 2

  1. [1] Jastrebo ff MM, Jastrebo ff PJ. Components of decreased sound tolerance: hyperacusis, misophonia, phonophobia. ITHS News Lett. 2001;2:5 -7. -
  2. [8] First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition. (SCID-I/P). New York (NY): Biometrics Research: New York State Psychiatric Institute; November 2002. -

Cited by

See all 35

Metadata

Authors
Alekri, J., & Al Saif, F.
Affiliations
  • Ministry of Health (BH)
  • Psychiatry Training Resident, Psychiatric Hospital, Ministry of Health, Manama, Kingdom of Bahrain
Venue
Psychiatry and Clinical Psychopharmacology
Published
2019-03-26
Volume
29
Issue
2
Pages
232-237
ISSN
  • 2475-0573 (ISSN-L)
  • 2475-0581
OpenAlex
W2924826112
Cited by
35
References
17
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 11 · 2022: 9 · 2021: 3 · 2019: 1
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Psychiatry and Clinical Psychopharmacology (publishedVersion, cc-by)
  • Psychiatry and Clinical Psychopharmacology (publishedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
Keywords
misophonia, suicide attempts, adolescents, selective serotonin reuptake inhibitors, escitalopram, fluoxetine, bupropion, adverse drug reactions, psychotherapy, anxiety, self-acceptance, coping strategies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-26, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-26 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suicidal misophonia: a case report. https://app.cochat.ai/papers/10.1080/24750573.2019.1597585
The paper
Alekri, J., & Al Saif, F. (2019). Suicidal misophonia: a case report. Psychiatry and Clinical Psychopharmacology. https://doi.org/10.1080/24750573.2019.1597585

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.